Boston Scientific Tweaks Full-Year Guidance to Narrow Range
27 October 2021 - 10:14PM
Dow Jones News
By Matt Grossman
Boston Scientific Corp. on Wednesday adjusted its full-year
earnings guidance by narrowing the forecast range compared with
previous guidance.
For the full year, the medical-devices company said it now
expects sales growth of 19% to 20% compared with last year, and
adjusted earnings of $1.60 a share to $1.62 a share. In July,
Boston Scientific had forecast adjusted earnings of $1.58 a share
to $1.62 a share for the full year.
In the fourth quarter, Boston Scientific anticipates year-over
year sales growth of 13% to 17% and adjusted earnings of 43 cents
to 45 cents a share.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
October 27, 2021 06:59 ET (10:59 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Apr 2024 to May 2024
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From May 2023 to May 2024